{"transactions":[{"id":702997,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":28555,"kind":"person","name":"Rooney Terence","position":1,"cik":"0002146464","reported_name":"Rooney Terence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-27T22:34:16.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":76000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares underlying this stock option shall vest on July 27, 2027, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date."}],"balance_after":76000,"derivative":{"exercise_price":110.05,"expiration_date":"2036-07-26","underlying":"Common Stock","underlying_shares":76000},"source":{"system":"sec-edgar","filing":"0001193125-26-318408","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526318408/ownership.xml","form_type":"4"}},{"id":702996,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":28555,"kind":"person","name":"Rooney Terence","position":1,"cik":"0002146464","reported_name":"Rooney Terence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-27T22:34:16.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annualinstallments following July 27, 2026, subject to the reporting person's continued employment through each vesting date."}],"balance_after":38000,"source":{"system":"sec-edgar","filing":"0001193125-26-318408","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526318408/ownership.xml","form_type":"4"}}]}